Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor‐based morphometry

A key question in designing MRI‐based clinical trials is how the main magnetic field strength of the scanner affects the power to detect disease effects. In 110 subjects scanned longitudinally at both 3.0 and 1.5 T, including 24 patients with Alzheimer's Disease (AD) [74.8 ± 9.2 years, MMSE: 22...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ho, April J., Hua, Xue, Lee, Suh, Leow, Alex D., Yanovsky, Igor, Gutman, Boris, Dinov, Ivo D., Leporé, Natasha, Stein, Jason L., Toga, Arthur W., Jack, Clifford R., Bernstein, Matt A., Reiman, Eric M., Harvey, Danielle J., Kornak, John, Schuff, Norbert, Alexander, Gene E., Weiner, Michael W., Thompson, Paul M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley Subscription Services, Inc., A Wiley Company 2009
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875376/
https://ncbi.nlm.nih.gov/pubmed/19780044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hbm.20882
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi